Effects of intrathecal Baclofen in reducing tremors in patients with multiple sclerosis

References

1. 1.↵
   1. Makhoul K,
   2. Ahdab R,
   3. Riachi N,
   4. Chalah MA,
   5. Ayache SS.

   Tremor in Multiple Sclerosis—An Overview and Future Perspectives. Brain Sci 2020; 10: 722.
2. 2.↵
   1. Ghosh R,
   2. Roy D,
   3. Dubey S,
   4. Das S,
   5. Benito-León J.

   Movement Disorders in Multiple Sclerosis: An Update. Tremor Other Hyperkinet Mov (N Y) 2022; 12: 14.
3. 3.↵
   1. Alusi SH,
   2. Macerollo A,
   3. MacKinnon CD,
   4. Rothwell JC,
   5. Bain PG.

   Tremor and Dysmetria in Multiple Sclerosis: A Neurophysiological Study. Tremor Other Hyperkinet Mov (N Y) 2021; 11: 30.
4. 4.↵
   1. Valipour, F,
   2. Esteki, A.

   Pattern Classification of Hand Movement Tremor in MS Patients with DBS ON and OFF. J Biomed Phys Eng 2022; 12: 21–30.
5. 5.↵
   1. Meador W,
   2. Salter AR,
   3. Rinker JR.

   Symptomatic Management of Multiple Sclerosis–Associated Tremor Among Participants in the NARCOMS Registry. Int J MS Care 2016; 18: 147–153.
6. 6.↵
   1. Hamad M,
   2. Holland R,
   3. Kamal N,
   4. Luceri R,
   5. Mammis A.

   Potential for Intrathecal Baclofen in Treatment of Essential Tremor. World Neurosurgery 2017; 105: 170–175.
7. 7.↵
   1. Pourmohammadi A,
   2. Riahi R,
   3. Hosseini SM,
   4. Adibi I.

   Pharmacological treatment of tremor in multiple sclerosis; a systematic review. Mult Scler Relat Disord 2022; 60: 103722.
8. 8.
   1. Uzunkopru C.

   Invasive Therapies in Multiple Sclerosis. Noro Psikiyatr Ars 2018; 55: S21–S25.
9. 9.
   van der Walt A. Addressing the treatment gap in MS-associated tremor: A new door opens. Mult Scler 2020; 26: 858.